Sectoral Asset Management’s Heron Therapeutics HRTX Stock Holding History

Sectoral Asset Management’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,400	Closed	-$197K	–	129
2020 Q2	$197K	Buy	+13,400	New	+$220K	0.02%	185
2018 Q4	–	Sell	-15,243	Closed	-$482K	–	116
2018 Q3	$482K	Buy	+15,243	New	+$568K	0.05%	88

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Sectoral Asset Management's HRTX Position: Q3 2020 in Review

Sectoral Asset Management sold out of Heron Therapeutics (HRTX) in Q3 2020, closing a stake of 13,400 shares — an estimated $197K sold.

Sectoral Asset Management first reported a position in HRTX in Q3 2018 and held it in 2 quarters. The position peaked at $482K in Q3 2018. 182 funds tracked by Wall St. Rank hold HRTX as of Q3 2020.

Sectoral Asset Management reported no remaining Heron Therapeutics position as of Q3 2020 after selling out during the quarter.
Sectoral Asset Management sold 13,400 Heron Therapeutics shares in Q3 2020, an estimated $197K.
Sectoral Asset Management first reported a position in Heron Therapeutics in Q3 2018 and held it in 2 quarters.
Sectoral Asset Management's Heron Therapeutics position peaked at $482K in Q3 2018.
182 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2020.

Based on Sectoral Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.